Krishnaswamy Yeleswaram

Insider Reports History

Location
Boston, MA
Signature
/s/ Troy Ignelzi, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Krishnaswamy Yeleswaram:

Company Role Class Num Shares Value Price $ Report Date Ownership
Rapport Therapeutics, Inc. Chief Development Officer Common Stock 296,991 $8,924,579 $30.05 31 Dec 2025 Direct
Rapport Therapeutics, Inc. Chief Development Officer Stock Option (Right to Buy) 110,000 03 Feb 2025 Direct

Insider Reports Filed by Krishnaswamy Yeleswaram

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RAPP Rapport Therapeutics, Inc. 31 Dec 2025 2 -$85,342 4 Chief Development Officer 05 Jan 2026, 16:19
RAPP Rapport Therapeutics, Inc. 03 Feb 2025 1 $0 4 Chief Development Officer 04 Feb 2025, 17:30
RAPP Rapport Therapeutics, Inc. 06 Jun 2024 1 $0 4 Chief Development Officer 10 Jun 2024, 19:42
RAPP Rapport Therapeutics, Inc. 06 Jun 2024 0 $0 3 Chief Development Officer 06 Jun 2024, 18:59